gene_id,uniprot_accession.x,gene_name.x,Entry.Name.x,Protein.names.x,Gene.Names.x,Gene.Ontology.biological.process.x,Gene.Ontology.IDs.x,PSC.56,PSC.52,PSC.54,PSC.61,PSC.64,PSC.73,PSC.76,PSC.81,PSC.59,PSC.57,PSC.69,PSC.67,PSC.71,PSC.75,PSC.78,PSC.83,PSC.0228,PSC.0187,PSC.0188,PSC.0174,PSC.0190,PSC.0231,PSC.0230,PSC.0219,PSC.0177,PSC.0186,PSC.0209,PSC.0203
g20837,P09215,KPCD_RAT,KPCD_RAT,Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],Prkcd Pkcd,apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; termination of signal transduction [GO:0023021],GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0006974; GO:0006979; GO:0008047; GO:0009410; GO:0009612; GO:0009749; GO:0014070; GO:0016020; GO:0016064; GO:0016363; GO:0018105; GO:0019899; GO:0019901; GO:0023021; GO:0030837; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0034644; GO:0035307; GO:0035556; GO:0036019; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043410; GO:0043560; GO:0043687; GO:0045471; GO:0046326; GO:0046627; GO:0046872; GO:0048471; GO:0050732; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:0106310; GO:1904385; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235,1611,3191,3957,2746,3398,2482,2653,2995,4906,8472,882,2797,2540,1708,1084,4593,3918,2366,2163,2708,2880,4101,1823,1264,1733,1177,1154,1359
g18475,Q0Q028,DFP3_ANTMY,DFP3_ANTMY,Putative defense protein 3 (DFP-3),,defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087],GO:0005576; GO:0042742; GO:0042832; GO:0045087,1514,5145,4198,3077,11493,7859,2787,2587,845,980,568,159,306,142,321,198,281,137,80,279,299,542,1406,3481,1461,2159,503,2583
g14045,Q5XJ85,MYD88_DANRE,MYD88_DANRE,Myeloid differentiation primary response protein MyD88,myd88,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response to wounding [GO:0090594]; innate immune response [GO:0045087]; monocyte activation [GO:0042117]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to molecule of bacterial origin [GO:0002237]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142],GO:0002218; GO:0002237; GO:0002283; GO:0002755; GO:0005737; GO:0005886; GO:0008063; GO:0030593; GO:0034142; GO:0035325; GO:0042117; GO:0042742; GO:0043123; GO:0045087; GO:0050830; GO:0070976; GO:0090594; GO:1901224; GO:1901532; GO:1901534,609,1113,1288,1102,1181,1688,1023,1265,2939,3785,2577,2229,2683,1354,645,2600,1868,853,1048,1055,1543,1993,745,408,451,546,771,579
g2677,P17676,CEBPB_HUMAN,CEBPB_HUMAN,CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5),CEBPB TCF5 PP9092,acute-phase response [GO:0006953]; brown fat cell differentiation [GO:0050873]; cellular response to amino acid stimulus [GO:0071230]; defense response to bacterium [GO:0042742]; embryonic placenta development [GO:0001892]; granuloma formation [GO:0002432]; hepatocyte proliferation [GO:0072574]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver regeneration [GO:0097421]; mammary gland epithelial cell differentiation [GO:0060644]; mammary gland epithelial cell proliferation [GO:0033598]; myeloid cell development [GO:0061515]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ovarian follicle development [GO:0001541]; positive regulation of biomineral tissue development [GO:0070169]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sodium-dependent phosphate transport [GO:2000120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of dendritic cell differentiation [GO:2001198]; regulation of DNA-templated transcription [GO:0006355]; regulation of interleukin-6 production [GO:0032675]; regulation of odontoblast differentiation [GO:1901329]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; T-helper 1 cell activation [GO:0035711]; transcription by RNA polymerase II [GO:0006366],GO:0000122; GO:0000779; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000979; GO:0000981; GO:0001227; GO:0001228; GO:0001541; GO:0001892; GO:0002432; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006357; GO:0006366; GO:0006953; GO:0006954; GO:0006955; GO:0016363; GO:0019900; GO:0030182; GO:0031490; GO:0032496; GO:0032675; GO:0032753; GO:0033598; GO:0034976; GO:0035035; GO:0035711; GO:0036488; GO:0042130; GO:0042742; GO:0042803; GO:0042826; GO:0043524; GO:0044389; GO:0045595; GO:0045600; GO:0045669; GO:0045670; GO:0045893; GO:0045944; GO:0050729; GO:0050873; GO:0060644; GO:0061515; GO:0070059; GO:0070169; GO:0071230; GO:0072574; GO:0090575; GO:0097421; GO:0120162; GO:0140467; GO:1901329; GO:1990647; GO:1990837; GO:2000120; GO:2001198,15719,21307,21016,23312,31732,21951,22689,21669,47078,54289,38333,38171,37386,72720,21913,108168,43385,34816,26545,55295,72214,47128,19421,15331,13491,11370,16772,13679
g16346,Q8R481,PERL_MESAU,PERL_MESAU,Lactoperoxidase (LPO) (EC 1.11.1.7) (Lacrimal gland peroxidase),LPO,defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; response to oxidative stress [GO:0006979],GO:0001580; GO:0004601; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0020037; GO:0036393; GO:0042742; GO:0046872; GO:0140825,31,32,0,0,0,3,21,34,67,37,171,236,181,44,235,263,146,554,93,5,5,51,43,17,0,30,0,44
g16630,B9EKI3,TMF1_MOUSE,TMF1_MOUSE,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Tmf1 Ara160 Gm153,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; male gonad development [GO:0008584]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid development [GO:0007286]; spermatid nucleus differentiation [GO:0007289],GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0006915; GO:0007286; GO:0007289; GO:0008584; GO:0010629; GO:0030317; GO:0030374; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:0071407; GO:1904019; GO:1904036; GO:2000845,1549,1872,2472,2244,2754,2634,2570,2638,917,779,921,1495,1132,173,1007,571,684,881,731,374,258,398,1549,813,854,1193,1110,1058
g580,Q9V9J3,SRC42_DROME,SRC42_DROME,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Src42A Src41 TK5 CG44128,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045087; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,358,492,546,647,589,604,570,540,1144,1505,375,1485,1121,731,777,1801,1330,1215,881,281,1661,1009,801,330,359,318,227,471
g12365,Q9SAL0,RGLG4_ARATH,RGLG4_ARATH,E3 ubiquitin-protein ligase RGLG4 (EC 2.3.2.27) (RING domain ligase 4),RGLG4 At1g79380 T8K14.20,defense response to bacterium [GO:0042742]; jasmonic acid mediated signaling pathway [GO:0009867]; response to wounding [GO:0009611],GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0009611; GO:0009867; GO:0042742; GO:0046872,261,379,452,336,442,528,540,646,523,913,824,993,837,653,367,832,616,935,430,374,327,532,164,213,139,129,158,96
g12643,Q5RAZ4,DHX15_PONAB,DHX15_PONAB,ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (DEAH box protein 15),DHX15,antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; RNA splicing [GO:0008380],GO:0003724; GO:0003725; GO:0005524; GO:0005689; GO:0005730; GO:0006397; GO:0008380; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0051607; GO:0071008; GO:0140374,3095,2918,2673,2208,3323,2882,3708,4028,2746,2475,3733,5929,3055,895,1984,2542,1692,1566,1144,1795,1114,1067,1419,1240,1257,1036,1249,1069
g3209,A9JTG5,HOIL1_DANRE,HOIL1_DANRE,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog),rbck1 zgc:175152,defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],GO:0004842; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0046872; GO:0048701; GO:0071600; GO:0071797; GO:0097039,1241,2061,2394,1314,1971,2090,2088,2448,1911,1398,1689,2513,1733,944,828,3155,2147,1319,1220,1265,1190,1758,1924,1285,1228,1299,1123,1107
g6741,Q5RBP9,MPEG1_PONAB,MPEG1_PONAB,"Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) [Cleaved into: Macrophage-expressed gene 1 protein, processed form]",MPEG1,adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468],GO:0002250; GO:0002468; GO:0002478; GO:0022829; GO:0030670; GO:0031410; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367,6090,12013,16990,5612,22156,19140,8002,13803,17949,27626,11455,23376,24672,70374,9454,239529,49234,22382,23373,142727,52322,18315,9592,7652,6979,7688,4528,4904
g12481,P81799,NAGK_RAT,NAGK_RAT,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase) (Muramyl dipeptide kinase) (EC 2.7.1.-) (N-acetyl-D-mannosamine kinase) (EC 2.7.1.60),Nagk,defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; response to muramyl dipeptide [GO:0032495],GO:0005524; GO:0006044; GO:0009384; GO:0019262; GO:0032495; GO:0042742; GO:0045087; GO:0045127; GO:0070434; GO:0160047,413,801,743,737,1153,854,689,663,703,1833,359,611,1130,347,945,791,830,577,471,446,386,740,651,507,600,521,293,371
g17238,F6R2G2,NLRC4_XENTR,NLRC4_XENTR,NLR family CARD domain-containing protein 4 (Ice protease-activating factor) (Ipaf),nlrc4 ipaf TGas028l14.1,apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; detection of bacterium [GO:0016045]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; regulation of apoptotic process [GO:0042981],GO:0005524; GO:0005829; GO:0006915; GO:0006954; GO:0016045; GO:0042742; GO:0042981; GO:0045087,332,484,767,451,760,694,608,741,908,2445,488,1229,668,984,334,834,1234,611,630,536,1860,1045,444,429,415,228,499,287
g15854,P20749,BCL3_HUMAN,BCL3_HUMAN,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),BCL3 BCL4 D19S37,"antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]",GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222,189,317,532,470,426,403,375,501,843,1327,299,1446,974,1278,442,4767,2120,1646,1032,1967,3483,1289,435,351,469,439,111,556
g6234,F1NV61,CASP7_CHICK,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686,0,172,8,5,7,98,133,134,312,298,305,3597,804,11,1818,230,105,266,70,10,0,116,35,14,7,9,14,51
g7488,Q9JI48,PLAC8_MOUSE,PLAC8_MOUSE,Placenta-specific gene 8 protein (Onzin) (Protein C15),Plac8,brown fat cell differentiation [GO:0050873]; defense response to bacterium [GO:0042742]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to cold [GO:0009409]; transcription by RNA polymerase II [GO:0006366],GO:0003682; GO:0005634; GO:0005654; GO:0006366; GO:0008284; GO:0009409; GO:0040015; GO:0042742; GO:0043066; GO:0045944; GO:0050873; GO:0120162,4369,6825,7336,5243,8132,10378,6193,10911,9027,11858,8575,8181,8908,6883,2702,10139,5938,3451,4547,7875,6649,5078,5433,4842,4063,3268,4524,5473
g2468,Q8R151,ZNFX1_MOUSE,ZNFX1_MOUSE,NFX1-type zinc finger-containing protein 1,Znfx1,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,1736,1312,2834,1137,2180,2330,2101,4263,1174,1391,1609,6265,2148,1345,1762,2901,4439,4796,3129,3085,2665,6531,4014,1813,784,1818,1138,700
g24110,Q5R8Z8,RAB14_PONAB,RAB14_PONAB,Ras-related protein Rab-14 (EC 3.6.5.2),RAB14,defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],GO:0000139; GO:0003924; GO:0005525; GO:0005802; GO:0005829; GO:0006895; GO:0008543; GO:0015031; GO:0019003; GO:0031901; GO:0032456; GO:0032880; GO:0042742; GO:0045335; GO:0045995; GO:0055037; GO:0090382,844,1067,1407,1094,1692,1450,1113,1202,1486,2220,895,1880,2004,726,665,1881,1448,1027,1083,1317,1355,1386,931,743,830,743,241,683
g16225,Q04721,NOTC2_HUMAN,NOTC2_HUMAN,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],NOTCH2,animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; atrioventricular node development [GO:0003162]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; bone remodeling [GO:0046849]; cell fate determination [GO:0001709]; cellular response to tumor cell [GO:0071228]; cholangiocyte proliferation [GO:1990705]; ciliary body morphogenesis [GO:0061073]; defense response to bacterium [GO:0042742]; embryonic limb morphogenesis [GO:0030326]; glomerular capillary formation [GO:0072104]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; intracellular signal transduction [GO:0035556]; intrahepatic bile duct development [GO:0035622]; left/right axis specification [GO:0070986]; marginal zone B cell differentiation [GO:0002315]; morphogenesis of an epithelial sheet [GO:0002011]; multicellular organism growth [GO:0035264]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; placenta blood vessel development [GO:0060674]; podocyte development [GO:0072015]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal tubule development [GO:0072014]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; wound healing [GO:0042060],GO:0000122; GO:0000139; GO:0000987; GO:0001228; GO:0001701; GO:0001709; GO:0001947; GO:0002011; GO:0002315; GO:0002437; GO:0003162; GO:0003184; GO:0005509; GO:0005576; GO:0005634; GO:0005654; GO:0005789; GO:0005886; GO:0005929; GO:0006915; GO:0006959; GO:0007219; GO:0007399; GO:0007411; GO:0009887; GO:0009986; GO:0010629; GO:0010838; GO:0016020; GO:0019899; GO:0030097; GO:0030326; GO:0030509; GO:0030513; GO:0035264; GO:0035556; GO:0035622; GO:0038023; GO:0042060; GO:0042742; GO:0043011; GO:0043065; GO:0043066; GO:0043235; GO:0045672; GO:0045944; GO:0046579; GO:0046849; GO:0051059; GO:0051152; GO:0060413; GO:0060674; GO:0061073; GO:0070374; GO:0070986; GO:0071228; GO:0072014; GO:0072015; GO:0072104; GO:0072574; GO:1902895; GO:1990705; GO:2001204,22,0,17,0,10,0,0,8,50,112,6,35,51,27,28,37,160,44,69,12,102,194,51,0,0,9,0,10
g4581,Q6NYB7,RAB1A_RAT,RAB1A_RAT,Ras-related protein Rab-1A (EC 3.6.5.2),Rab1A Rab1,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; cell migration [GO:0016477]; COPII-coated vesicle cargo loading [GO:0090110]; defense response to bacterium [GO:0042742]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; growth hormone secretion [GO:0030252]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; positive regulation of glycoprotein metabolic process [GO:1903020]; positive regulation of interleukin-8 production [GO:0032757]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446]; vesicle transport along microtubule [GO:0047496],GO:0000045; GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006897; GO:0006914; GO:0007030; GO:0012505; GO:0016477; GO:0030252; GO:0032402; GO:0032482; GO:0032757; GO:0034446; GO:0042470; GO:0042742; GO:0043025; GO:0047496; GO:0090110; GO:0098793; GO:1903020,3400,5293,6911,6287,8924,8150,5219,6244,7025,10492,4264,7568,8076,4998,3110,10910,6773,3881,4243,6467,5721,4927,4675,3373,4540,3580,3639,3081
g8842,A7X4K1,WAP1_PHIOL,WAP1_PHIOL,Waprin-Phi1,,defense response to bacterium [GO:0042742]; disruption of cell wall in another organism [GO:0044278],GO:0004867; GO:0005576; GO:0005615; GO:0042742; GO:0044278,463,46,174,20,42,132,178,71,357,245,1535,253,1828,166,125,385,4444,3890,945,300,62,525,697,471,182,112,31,144
g21382,Q8WWQ8,STAB2_HUMAN,STAB2_HUMAN,"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]",STAB2 FEEL2 FELL FEX2 HARE,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],GO:0001525; GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0005886; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0015035; GO:0030169; GO:0030214; GO:0030666; GO:0042742; GO:0050830,246,368,721,355,555,350,529,516,488,848,420,792,437,291,179,714,940,324,504,522,801,625,699,414,397,400,297,342
g2565,Q924T7,RNF31_MOUSE,RNF31_MOUSE,E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (Putative Ariadne-like ubiquitin ligase) (PAUL) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31),Rnf31 Paul,CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852]; tumor necrosis factor-mediated signaling pathway [GO:0033209],GO:0000209; GO:0004842; GO:0005829; GO:0008270; GO:0009898; GO:0016567; GO:0023035; GO:0031625; GO:0033209; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1904417; GO:1990450,904,2176,2067,1320,1766,1725,2844,3224,2001,3471,589,4043,1495,1747,741,4157,4607,3480,2293,2553,4383,3822,2725,1296,832,2108,1625,1596
g2563,Q96EP0,RNF31_HUMAN,RNF31_HUMAN,E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.31) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein),RNF31 ZIBRA,CD40 signaling pathway [GO:0023035]; defense response to bacterium [GO:0042742]; negative regulation of necroptotic process [GO:0060546]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of xenophagy [GO:1904417]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; T cell receptor signaling pathway [GO:0050852],GO:0000209; GO:0004842; GO:0005829; GO:0008270; GO:0009898; GO:0023035; GO:0031625; GO:0035631; GO:0036435; GO:0042742; GO:0042802; GO:0043123; GO:0043130; GO:0050852; GO:0051092; GO:0060546; GO:0061630; GO:0070530; GO:0071797; GO:0097039; GO:1903955; GO:1904417; GO:1990450,298,713,464,468,494,543,880,977,686,997,187,1230,420,318,317,1204,1197,1006,766,664,1094,986,784,395,288,479,356,447
g15687,Q9Z2F6,BCL3_MOUSE,BCL3_MOUSE,B-cell lymphoma 3 protein homolog (BCL-3),Bcl3,"antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]",GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006606; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032996; GO:0033257; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0045064; GO:0045727; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0070231; GO:0070233; GO:0140297; GO:1901222,1936,4150,5553,3248,7739,3624,5859,6765,14865,19878,7782,15157,9373,19053,4174,30205,25530,11440,9278,13943,39182,17132,6180,4590,3899,4473,3772,3383
g1388,Q9ULY5,CLC4E_HUMAN,CLC4E_HUMAN,C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE),CLEC4E CLECSF9 MINCLE UNQ218/PRO244,antifungal innate immune response [GO:0061760]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway [GO:0038094]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production [GO:0001819]; T cell differentiation involved in immune response [GO:0002292],GO:0001819; GO:0001891; GO:0002221; GO:0002292; GO:0005509; GO:0005886; GO:0009897; GO:0016020; GO:0030246; GO:0030670; GO:0038094; GO:0038187; GO:0042742; GO:0042995; GO:0045087; GO:0051861; GO:0061760,0,0,0,0,0,20,0,0,113,0,15,9,0,0,8,252,156,1098,299,0,0,490,0,88,16,0,23,7
g17537,F1NV61,CASP7_CHICK,CASP7_CHICK,Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],CASP7,defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508],GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0042742; GO:0043525; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686,66,17,32,21,114,744,64,55,4833,4832,12509,5305,7950,2757,1783,9548,5559,11793,5636,626,4794,9398,36,134,79,29,425,71
g20844,O75179,ANR17_HUMAN,ANR17_HUMAN,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),ANKRD17 GTAR KIAA0697,blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],GO:0000785; GO:0001673; GO:0001955; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006275; GO:0016020; GO:0031965; GO:0042742; GO:0043123; GO:0045087; GO:0045787; GO:0051151; GO:1900087; GO:1900245; GO:1900246,142,111,232,124,190,233,148,84,38557,52675,7530,23360,22161,19458,4587,34126,37138,8225,11472,1189,31684,45483,167,109,86,37,187,142